Lode Resources may have found more than antimony at Montezuma. What does it mean for ASX:LDR investors?
Read More Pharma Industry News AbbVie to expand immunology pipeline with Nimble Therapeutics acquisition In a significant move to solidify its presence in immunology, AbbVie has announced the acquisition of Nimble Therapeutics,… byPallavi MadhirajuDecember 14, 2024